Vertaling van "1 symptomatic vertebral rr " (Frans → Nederlands) :

N=1 Symptomatic vertebral RR=0.62 (95% CI 0.47-0.83) # 2/6572 36 m Non-vertebral # RR=0.86 (95% CI 0.75-0.98) NNT=58 Subgroup analysis in 80+ (n=1488) showed efficacy
N=1 Symptomatic vertebral # RR=0.62 (95% CI 0.47-0.83) 2/6572 36 m Non-vertebral # RR=0.86 (95% CI 0.75-0.98) NNT=58

Non-vertebral # RR= 0.80 (95% CI 0.72-0.90)
2-3 y vertebral # RR= 0.61 (95% CI 0.50-0.76)

4/2785 1-3 y Vertebral # RR= 0.55 (95% CI 0.43-0.69) NNT 20-42 (lower in higher risk groups)
1-3 y Vertebral # RR= 0.55 (95% CI 0.43-0.69) NNT 20-42 (lower in higher risk groups)

3/4919 1-3 y Vertebral # RR= 0.70 (95% CI 0.54-0.91) in favour of ibandronate
Vit D + Ca ibandronate (any dose) vs. placebo

Clinical vertebral # zol= 0.5% vs pla= 2.6% RR= 0.23 (95% CI 0.14-0.37)
clinical vertebral # zol= 0.5% vs pla= 2.6% RR= 0.23 (95% CI 0.14-0.37)

3/5254 24-36 m Vertebral # (RX) RR=0.63 (95% CI 0.56-0.71) NNT=13/3y Subgroup analysis in 80+ (n=1488) showed efficacy
3/5254 24-36 m Vertebral # (RX) RR=0.63 (95% CI 0.56-0.71) NNT=13/3y Subgroup analysis in 80+ (n=1.488) showed efficacy

Non vertebral # zol= 8% vs pla= 10.7% RR= 0.75 (95% CI 0.64-0.87)
non vertebral # zol= 8% vs pla= 10.7% RR= 0.75 (95% CI 0.64-0.87)